Launch Strategy & Commercial Planning
Market assessment, positioning, forecasting, and the launch plan that ties them together. Built for the company you are, not a scaled-down version of a top-twenty playbook.
What this includesCommercial strategy for emerging biopharma
Cultivating the ground between clinical data and commercial success.
Tilth Health Strategies helps emerging biopharma companies build the commercial foundation a first launch demands, then supplies the senior leadership to carry it through.
The name
Tilth is the condition of soil that makes growth possible.
It describes ground that holds water, admits air, and gives roots something to work with. You can't produce it the week before planting. It comes from work done seasons earlier.
Commercial readiness works the same way. Most of what decides whether a therapy reaches patients gets settled long before the first prescription: how you shape the evidence, how you build the value story, how well you understand the market, and whether your organization can sell what it spent a decade developing.
I work that ground early, so that launch is an execution problem rather than a discovery one.
What I do
Two ways to work together.
Fractional & Interim Commercial Leadership
Senior commercial leadership working inside your team, through a launch or through a gap in the org chart. Full accountability without a full-time hire.
What this includesWhy a smaller firm
Three things that hold true on every engagement.
The person you meet does the work
There's no layered team here, and no junior analyst learning your market on your budget. Whoever is on the first call is the one building the model.
Recommendations you can afford to act on
A plan that assumes a sixty-person field force is worse than no plan. Everything I recommend is sized against the budget and headcount you actually have.
Engagements end in decisions
The work is built around the decisions in front of you, and it ends with those decisions made, written down, and ready to take to a board.
Who I work with
Emerging biopharma.
Companies approaching a first launch, or building commercial capability for the first time.
- Clinical-stage companies preparing for a first commercial product
- Teams that need a commercial plan a board and its investors will find credible
- Organizations building a commercial function from a standing start
- Companies between commercial leaders, or between a founding team and a first commercial hire
- Programs where the science is strong and the path to the patient isn't yet defined
Planning a launch?
The most useful conversations happen earlier than most teams expect. If a first commercial product is anywhere on your horizon, it's worth a call.